Monomorphic epitheliotropic intestinal T‐cell lymphoma (MEITL) is a rare, aggressive malignancy with a median overall survival (OS) of 7–15 months. The Newcastle regimen, comprising cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP), ifosfamide, etoposide, and epirubicin (IVE), and intermediate‐dose meth...
M. Suh, Hyungwoo Cho, H. Go et al.· eJHaem· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.